TTM
$29.73B
YoY change
+2.4%
5Y CAGR
+3.6%
Peak year (2015)
$32.64B
Cumulative revenue
$392.61B
Revenue history chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: $29.44B
Revenue growth chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: +2.4%
Revenue history table for Gilead Sciences (GILD) from 1990 to 2025
| 2025 | $29.44B | +2.4% | +$688.00M | ||
| 2024 | $28.75B | +6.0% | +$1.64B | ||
| 2023 | $27.12B | -0.6% | −$165.00M | ||
| 2022 | $27.28B | -0.1% | −$24.00M | ||
| 2021 | $27.30B | +10.6% | +$2.62B | ||
| 2020 | $24.69B | +10.0% | +$2.24B | ||
| 2019 | $22.45B | +1.5% | +$322.00M | ||
| 2018 | $22.13B | -15.2% | −$3.98B | ||
| 2017 | $26.11B | -14.1% | −$4.28B | ||
| 2016 | $30.39B | -6.9% | −$2.25B | ||
| 2015 | $32.64B | +31.1% | +$7.75B | ||
| 2014 | $24.89B | +122.2% | +$13.69B | ||
| 2013 | $11.20B | +15.5% | +$1.50B | ||
| 2012 | $9.70B | +15.7% | +$1.32B | ||
| 2011 | $8.39B | +5.5% | +$435.96M | ||
| 2010 | $7.95B | +13.4% | +$938.04M | ||
| 2009 | $7.01B | +31.4% | +$1.68B | ||
| 2008 | $5.34B | +26.1% | +$1.11B | ||
| 2007 | $4.23B | +39.8% | +$1.20B | ||
| 2006 | $3.03B | +49.2% | +$997.74M | ||
| 2005 | $2.03B | +53.1% | +$703.78M | ||
| 2004 | $1.32B | +52.6% | +$456.76M | ||
| 2003 | $867.86M | +85.9% | +$401.07M | ||
| 2002 | $466.79M | +99.7% | +$233.02M | ||
| 2001 | $233.77M | +19.5% | +$38.21M | ||
| 2000 | $195.56M | +15.7% | +$26.55M | ||
| 1999 | $169.00M | +11.8% | +$17.90M | ||
| 1998 | $151.10M | +14.2% | +$18.80M | ||
| 1997 | $132.30M | +296.1% | +$98.90M | ||
| 1996 | $33.40M | +1137.0% | +$30.70M | ||
| 1995 | $2.70M | -44.9% | −$2.20M | ||
| 1994 | $4.90M | — | — | ||
| 1992 | $4.20M | +50.0% | +$1.40M | ||
| 1991 | $2.80M | +115.4% | +$1.50M | ||
| 1990 | $1.30M | — | — |
- 2025$29.44B+2.4%
- 2024$28.75B+6.0%
- 2023$27.12B-0.6%
- 2022$27.28B-0.1%
- 2021$27.30B+10.6%
- 2020$24.69B+10.0%
- 2019$22.45B+1.5%
- 2018$22.13B-15.2%
- 2017$26.11B-14.1%
- 2016$30.39B-6.9%
- 2015$32.64B+31.1%
- 2014$24.89B+122.2%
- 2013$11.20B+15.5%
- 2012$9.70B+15.7%
- 2011$8.39B+5.5%
- 2010$7.95B+13.4%
- 2009$7.01B+31.4%
- 2008$5.34B+26.1%
- 2007$4.23B+39.8%
- 2006$3.03B+49.2%
- 2005$2.03B+53.1%
- 2004$1.32B+52.6%
- 2003$867.86M+85.9%
- 2002$466.79M+99.7%
- 2001$233.77M+19.5%
- 2000$195.56M+15.7%
- 1999$169.00M+11.8%
- 1998$151.10M+14.2%
- 1997$132.30M+296.1%
- 1996$33.40M+1137.0%
- 1995$2.70M-44.9%
- 1994$4.90M—
- 1992$4.20M+50.0%
- 1991$2.80M+115.4%
- 1990$1.30M—
Revenue values are taken from Gilead Sciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's current revenue (TTM) is $29.73B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual revenue for Gilead Sciences (GILD) came in at $29.44B – edged up 2.4% year-over-year.
Over 2020–2025 (5 years), Gilead Sciences revenue expanded at a +3.6% compound annual rate, sustaining 2 straight years of year-over-year growth.
Gilead Sciences revenue declined from $32.64B in 2015 to $29.44B in 2025, a 9.8% drawdown.
$32.64B stands as the all-time-high annual revenue, posted in 2015, against a low of $1.30M during 1990.
Gilead Sciences Revenue by Year
Gilead Sciences Revenue 2025: $29.44B
Gilead Sciences revenue in 2025 was $29.44B, edged up 2.4% from 2024.
Gilead Sciences Revenue 2024: $28.75B
2024's revenue for Gilead Sciences came in at $28.75B, grew 6.0% from 2023.
Gilead Sciences Revenue 2023: $27.12B
Gilead Sciences posted revenue of $27.12B in 2023, edged down 0.6% below 2022.
Gilead Sciences Revenue 2022: $27.28B
In 2022, Gilead Sciences reported revenue of $27.28B, edged down 0.1% below 2021.
Gilead Sciences Revenue 2021: $27.30B
Gilead Sciences revenue in 2021 was $27.30B.
See more financial history for Gilead Sciences (GILD).
Sector peers by Revenue
Healthcare peers of Gilead Sciences (GILD), ranked by their latest revenue
| $447.57B | |
| $94.19B | |
| $65.18B | |
| $64.93B | |
| $61.16B | |
| $58.74B | |
| $48.18B | |
| $36.74B |
- $447.57B
- $94.19B
- $65.18B
- $64.93B
- $61.16B
- $58.74B
- $48.18B
- $36.74B
Frequently asked questions
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation